Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Multiple Sclerosis

Free Subscription 18.05.2026 1 AJNR Am J Neuroradiol 1 Arch Phys Med Rehabil 1 Brain 1 Immunol Cell Biol 1 J Neurol 1 J Neurol Neurosurg Psychiatry 2 J Neurol Sci 7 Lancet Neurol 2 Mult Scler 1 Neurol Clin Pract 1 Neurology 1 PLoS One 5 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. MOON HH, Jeong E, Alanazi M, Nam Y, et al
   Associations between Paramagnetic Rim Lesions and Gadolinium Contrast Permeability of Perivascular Spaces in Patients with Multiple Sclerosis: A T1 mapping study.
   AJNR Am J Neuroradiol. 2026 May 8:ajnr.A9405. doi: 10.3174/ajnr.A9405.
   PubMed         Abstract available
   
   

   
   Arch Phys Med Rehabil

2. STOWELL JF, Ladipo VA, Jeter R, Galen SS, et al
   ASSESSING DISABILITY LEVEL AND FATIGUE IN MULTIPLE SCLEROSIS WITH SMART SOCK SENSOR TECHNOLOGY.
   Arch Phys Med Rehabil. 2026 May 13:S0003-9993(26)00707.
   PubMed         Abstract available
   
   

   
   Brain

3. GEORGIEVA ZG, Howlett SK, Rainbow DB, Coppard V, et al
   Low-dose IL-2 fails to expand Tregs after alemtuzumab: insight into impaired immune tolerance in multiple sclerosis.
   Brain. 2026 May 13:awag171. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Immunol Cell Biol

4. MUNZ C
   Neuroinflammation as a result of non-neurotropic herpesvirus infection.
   Immunol Cell Biol. 2026;104:443-451.
   PubMed         Abstract available
   
   

   
   J Neurol

5. FILIPPI M, D'Amico E, Brescia Morra V, Zanetta C, et al
   Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort.
   J Neurol. 2026;273:302.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

6. HOGENBOOM L, McLean A, Schoof L, Taylor L, et al
   Predictors of B-cell repopulation in people with multiple sclerosis treated with ocrelizumab: insights from two large cohorts.
   J Neurol Neurosurg Psychiatry. 2026 May 8:jnnp-2026-338533.
   PubMed         Abstract available
   
   

   
   J Neurol Sci

7. SHARMA A, Kumar P, Morris S
   Comment on "Ocrelizumab modulates the IL-2 signaling pathway and associated lncRNAs in multiple sclerosis".
   J Neurol Sci. 2026;487:125950.
   PubMed        
   
   
8. KUMAR M, Pandey M, Rao BN
   Comment on "predictors of short-term, relapse-independent progression in multiple sclerosis: A machine learning approach based on clinical data and conventional MRI-derived features".
   J Neurol Sci. 2026;487:125924.
   PubMed        
   
   

   
   Lancet Neurol

9. TOOSY A, Oertel FC, Petzold A, Albrecht P, et al
   Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
   Lancet Neurol. 2026;25:539-540.
   PubMed        
   
   
10. OKUDA DT, Kantarci OH, Siva A, Pelletier D, et al
    Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
    Lancet Neurol. 2026;25:539.
    PubMed        
    
    
11. KRIEGER S
    Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
    Lancet Neurol. 2026;25:540-541.
    PubMed        
    
    
12. MONTALBAN X, Oh J, Coetzee T, Thompson AJ, et al
    Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis - Authors' reply.
    Lancet Neurol. 2026;25:542-543.
    PubMed        
    
    
13. ZETTL UK, Rommer PS, Wattjes MP, Tumani H, et al
    Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
    Lancet Neurol. 2026;25:542.
    PubMed        
    
    
14. SONODA Y, Hagiwara A, Tomizawa Y, Hatano T, et al
    Flip angle in susceptibility-weighted imaging for the diagnosis of multiple sclerosis.
    Lancet Neurol. 2026;25:544.
    PubMed        
    
    
15. SATI P, Barkhof F, Reich DS, Ontaneda D, et al
    Flip angle in susceptibility-weighted imaging for the diagnosis of multiple sclerosis - Authors' reply.
    Lancet Neurol. 2026;25:545.
    PubMed        
    
    

    
    Mult Scler

16. AMIN M, Nakamura K, Thoomukuntla B, Carlson AK, et al
    Paramagnetic rim lesions on 7T MRI after autologous hematopoietic cell transplantation.
    Mult Scler. 2026;32:647-651.
    PubMed         Abstract available
    
    
17. PALLADINO R, Marrie RA, Affinito G, Majeed A, et al
    Recalibration and external validation of vascular risk calculators for multiple sclerosis: A population-based study using CPRD data in England, 1987-2023.
    Mult Scler. 2026 May 12:13524585261444243. doi: 10.1177/13524585261444243.
    PubMed         Abstract available
    
    

    
    Neurol Clin Pract

18. SIGNORI A, Montobbio N, Bovis F, Ponzano M, et al
    Uncoupling Relapse Reduction and Disability Progression: Evidence From Tolebrutinib Studies.
    Neurol Clin Pract. 2026;16:e200612.
    PubMed         Abstract available
    
    

    
    Neurology

19. KIM W, Watt CL, Fung SG, Yoo S, et al
    Multiple Sclerosis and Outpatient Physician Care in the Last Years of Life: A Population-Based Study.
    Neurology. 2026;106:e218067.
    PubMed         Abstract available
    
    

    
    PLoS One

20. DASTANI M, Sajjadi MS, Yamout B, Arab Bafrani M, et al
    Evaluation of the performance of large language models in responding to medical questions related to multiple sclerosis: A case study of large language models including ChatGPT, Gemini, Grok and Copilot.
    PLoS One. 2026;21:e0346445.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

21. LEBRUN-FRENAY C
    Evolving MS diagnostic criteria: Progress and challenges.
    Rev Neurol (Paris). 2026;182:323-328.
    PubMed         Abstract available
    
    
22. MARIGNIER R, Leal Rato M
    NMOSD and MOGAD: Updates on diagnostic criteria.
    Rev Neurol (Paris). 2026;182:344-351.
    PubMed         Abstract available
    
    
23. COBO-CALVO A, Rovira A, Tintore M
    Diagnostic pitfalls and complex cases in MS.
    Rev Neurol (Paris). 2026;182:335-343.
    PubMed         Abstract available
    
    
24. LOUAPRE C, Beigneux Y, Maestri F, Meyniel C, et al
    Remyelination and neuroprotection translational trials: Lessons from optic neuritis.
    Rev Neurol (Paris). 2026 Apr 10:S0035-3787(26)00502.
    PubMed         Abstract available
    
    
25. GALBUSERA R, Stadelmann C, Granziera C
    Imaging myelin content changes: A bridge between tissue and clinics.
    Rev Neurol (Paris). 2026 Apr 14:S0035-3787(26)00505.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum